IQVIA Holdings, Inc. (IQV)
261.77
+4.47
(+1.74%)
USD |
NYSE |
Sep 11, 16:00
263.76
+1.99
(+0.76%)
Pre-Market: 05:34
IQVIA Holdings Enterprise Value : 57.38B for Sept. 11, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 11, 2026 | 57.38B |
| September 10, 2026 | 56.64B |
| September 09, 2026 | 56.59B |
| September 08, 2026 | 56.96B |
| September 04, 2026 | 58.37B |
| September 03, 2026 | 59.00B |
| September 02, 2026 | 57.72B |
| September 01, 2026 | 56.82B |
| August 31, 2026 | 57.28B |
| August 28, 2026 | 57.38B |
| August 27, 2026 | 57.48B |
| August 26, 2026 | 57.34B |
| August 25, 2026 | 56.99B |
| August 24, 2026 | 57.13B |
| August 21, 2026 | 57.06B |
| August 20, 2026 | 56.44B |
| August 19, 2026 | 55.32B |
| August 18, 2026 | 53.80B |
| August 17, 2026 | 54.00B |
| August 14, 2026 | 53.25B |
| August 13, 2026 | 54.05B |
| August 12, 2026 | 54.08B |
| August 11, 2026 | 54.43B |
| August 10, 2026 | 54.12B |
| August 07, 2026 | 53.58B |
| Date | Value |
|---|---|
| August 06, 2026 | 52.55B |
| August 05, 2026 | 53.14B |
| August 04, 2026 | 51.85B |
| August 03, 2026 | 52.70B |
| July 31, 2026 | 52.98B |
| July 30, 2026 | 53.43B |
| July 29, 2026 | 55.04B |
| July 28, 2026 | 54.28B |
| July 27, 2026 | 49.39B |
| July 24, 2026 | 48.54B |
| July 23, 2026 | 48.42B |
| July 22, 2026 | 46.97B |
| July 21, 2026 | 47.48B |
| July 20, 2026 | 47.85B |
| July 17, 2026 | 48.24B |
| July 16, 2026 | 48.94B |
| July 15, 2026 | 48.33B |
| July 14, 2026 | 48.50B |
| July 13, 2026 | 48.45B |
| July 10, 2026 | 48.50B |
| July 09, 2026 | 48.69B |
| July 08, 2026 | 47.83B |
| July 07, 2026 | 48.57B |
| July 06, 2026 | 48.19B |
| July 02, 2026 | 48.37B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Charles River Laboratories International, Inc. | 16.15B |
| Medpace Holdings, Inc. | 16.00B |
| Moderna, Inc. | 53.59B |
| Fortrea Holdings, Inc. | 2.585B |
| OmniAb, Inc. | 558.66M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 258.00M |
| Revenue (Quarterly) | 4.37B |
| Total Expenses (Quarterly) | 4.114B |
| EPS Diluted (Quarterly) | 1.530 |
| Gross Profit Margin (Quarterly) | 26.20% |
| Profit Margin (Quarterly) | 5.90% |
| Earnings Yield | 3.08% |
| Operating Earnings Yield | 5.30% |
| Normalized Earnings Yield | 3.268 |